# The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

> **NCT00385203** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 35 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors
- Soft Tissue Sarcomas

## Interventions

- **DRUG:** AZD2171

## Key facts

- **NCT ID:** NCT00385203
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-06
- **Final completion:** 2009-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385203, "The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00385203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*